These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 145605)

  • 21. [Almotriptan in the treatment of migraine attacks in clinical practice: results of the TEA 2000 observational study].
    Pascual J; Láinez JM; Leira R; Titus F; Mateos V; Galván J;
    Neurologia; 2003; 18(1):7-17. PubMed ID: 12590376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Physiopathology of migraine].
    Goadsby PJ; Lance JW
    Rev Prat; 1990 Feb; 40(5):389-93. PubMed ID: 1968676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subcutaneous sumatriptan compared with usual acute treatments for migraine: clinical and pharmacoeconomic evaluation.
    Laloux P; Vakaet A; Monseu G; Jacquy J; Bourgeois P; van der Linden C
    Acta Neurol Belg; 1998 Dec; 98(4):332-41. PubMed ID: 9922821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: a multicenter, prospective, open-label, two-attack, crossover study.
    Bell CF; Foley KA; Barlas S; Solomon G; Hu XH
    Clin Ther; 2006 Jun; 28(6):872-80. PubMed ID: 16860170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction in the therapeutic intensity of abortive migraine drug use during ACE inhibition therapy--a pilot study.
    Rahimtoola H; Buurma H; Tijssen CC; Leufkens HG; Egberts AC
    Pharmacoepidemiol Drug Saf; 2004 Jan; 13(1):41-7. PubMed ID: 14971122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: a pooled analysis of data from six clinical trials.
    Winner P; Landy S; Richardson M; Ames M
    Clin Ther; 2005 Nov; 27(11):1785-94. PubMed ID: 16368449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of rizatriptan in the treatment of acute, multiple migraine attacks.
    Saper JR
    Neurology; 2000; 55(9 Suppl 2):S15-8. PubMed ID: 11089514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo antiserotoninergic effects of 1-isopropylnoradreno-chrome-5-monosemicarbazone (Divascan).
    Prato A; Amico-Roxas M; Canonico PL; Drago F; Clementi G
    Pharmacol Res Commun; 1980 Sep; 12(8):751-6. PubMed ID: 7443760
    [No Abstract]   [Full Text] [Related]  

  • 29. Review of clinical trials using early acute intervention with oral triptans for migraine management.
    Dowson AJ; Mathew NT; Pascual J
    Int J Clin Pract; 2006 Jun; 60(6):698-706. PubMed ID: 16805756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Headache: classification, mechanism and principles of therapy, with particular reference to migraine.
    Lance JW
    Recenti Prog Med; 1989 Dec; 80(12):673-80. PubMed ID: 2516913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Economic evaluation of acute migraine attack treatment with triptans in Spain].
    Gracia-Naya M; Rejas Gutiérrez J; Latorre Jiménez A; González Garcia P
    Neurologia; 2005 Apr; 20(3):121-32. PubMed ID: 15815947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapy of migraine. Clinical experience with Migraeflux, a new migraine drug].
    Philipp M
    Fortschr Med; 1977 Jan; 95(2):107-10. PubMed ID: 832830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Latency and evidence of pathology in migraine: clinico-pharmacological and therapeutic considerations on a drug antagonist of serotonin and histamine].
    Anselmi B; Del Bianco PL; Sicuteri F; Bavazzano A
    Clin Ter; 1969 Oct; 51(2):117-30. PubMed ID: 4391539
    [No Abstract]   [Full Text] [Related]  

  • 34. [BC-105 preparation in treatment of migraine].
    Zwozdziak W
    Wiad Lek; 1973 Dec; 26(23):2207-9. PubMed ID: 4588418
    [No Abstract]   [Full Text] [Related]  

  • 35. Sumatriptan for the treatment of undifferentiated primary headaches in the ED.
    Miner JR; Smith SW; Moore J; Biros M
    Am J Emerg Med; 2007 Jan; 25(1):60-4. PubMed ID: 17157685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Symptomatic relief of migraine: multicenter comparison of Cafergot P-B, Cafergot, and placebo.
    Friedman AP; Di Serio FJ; Hwang DS
    Clin Ther; 1989; 11(1):170-82. PubMed ID: 2497984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in migraine management: implications for managed care organizations.
    Dodick DW; Lipsy RJ
    Manag Care; 2004 May; 13(5):45-51. PubMed ID: 15181689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Removing barriers to appropriate migraine treatment: formulary limitations and triptan package size.
    Silberstein SD; Dodick D; Kesslick J
    Headache; 2005 Oct; 45(9):1250-4. PubMed ID: 16178957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
    Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
    Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dihydroergotamine: role in the treatment of migraine.
    Schürks M
    Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1141-8. PubMed ID: 19624283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.